UNLIMITED OPPORTUNITIES

TO ENTER THE GLOBAL MARKET.

Innovation without barrier

私たちのミッションは日本発の技術の価値を高め、
世界に送り出すことです3

1 - 1

◀

▶

J A P A N T E C H N O L O G Y G R O U P 　N E E D S L I S T I N G

TECHNOLOGY NEEDS

JTG | TECHNOLOGY IN DEMAND

Inflammatory and Immune-Mediated Dermatologic Disorders (Global)

Request for Proposals (RFP)

Background

WANTED TECHNOLOGIES 2021

ACCESS TO INNOVATION

JTG NEWS & INFO

Wellspring Announces Japan Technology Group as a Channel Partner for Japan Market

Wellspring Worldwide, the leader in software for technology transfer and corporate innovation management, today appointed Japan Technology Group (JTG) as a strategic channel partner in Japan.
Click to see full details...

Contract to research and identify European industrial technologies of high cooperation and business potential for Japan.

Japan Technology Group as member of the International Consortium has been awarded a contract to research and identify European industrial technologies of high cooperation and business potential for Japan. Click to see full details...

Details..

See here for more details about the partnership with
i-deals.

JAPAN TECHNOLOGY GROUP, Inc. has signed a MOU with I-DEALS INNOVATION &

TECHNOLOGY VENTURING SERVICES, S.L.U ( everis Group, subsidiary of the NTT Data Group)

What people are saying
about JTG

“JTG has proven to be very dependable and as advertised, they are extremely well connected to the research community in Japan. Their core expertise and approach to doing business are in alignment with our objectives. As a result, we have been able to establish several strategic relationships and collaboration opportunities.”

University of Hawai‘i
Larry Cutshaw
Director Business Development, Office of the Vice President for Research and Innovation

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program.

Conditions & Requirements etc.

Pfizer Global Medical Grants (GMG)

Specific areas of interest

The intent of this Request for Proposal (RFP) is to support preclinical, clinical and outcomes research through a competitive grant program with the intent to increase medical knowledge in the diagnosis and management of inflammatory and immune-mediated dermatologic disorders. For all areas, there is a particular interest in supporting research on treatment response in in all Fitzpatrick skin types. For atopic dermatitis, there is complementary interest in low disease activity monitoring.

Date RFP Issued: December 16, 2020

Geographic Scope: Global (excluding U.S.)*

*The Inflammatory and Immune-Mediated Dermatologic Disorders Competitive Grant Program for the U.S. can be found here.

Clinical Area: Inflammatory and Immune-mediated Dermatologic Disorders

Application Due Date: March 10, 2021

Link to full documentation